A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal (REVEAL)

Allergan

Status: Completed

Conditions: Dry Eye Syndromes

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT01882413

GMA-RES-012-001

Details and patient eligibility

About

This study will evaluate the prevalence of inflammatory dry eye disease in patients prior to cataract surgery. No treatment is administered in this study.

Enrollment: 204 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Scheduled to undergo cataract removal surgery

Exclusion criteria

• Current use of eye drops or oral medications for allergic conjunctivitis
• Serious ocular injury, intraocular surgery, or refractive surgery within 6 months in the study eye
• Use of a contact lens within 4 weeks

Trial design

204 participants in 1 patient group

Patients with Planned Cataract Removal

Description:

Patients with planned cataract removal surgery are evaluated for the presence of inflammatory dry eye disease. No treatment is administered.

Treatment:

Other: No intervention